# Anthropic Calendar Forward-looking beats calendar for [[Anthropic]]. Tracks recurring reporting cycles and upcoming dated events. The calendar answers the question: when should we be watching, and for what? ## Recurring beats | Beat | Frequency | What to check | Next expected | |------|-----------|--------------|--------------| | Model releases | Irregular (~quarterly) | New Claude versions, capability jumps, safety evaluations | Ongoing — Opus 4.8 (May 2026), Fable 5 (Jun 2026) | | Lobbying disclosures | Quarterly | Federal lobbying spend via OpenSecrets; compare to [[OpenAI]] | Q2 2026 (Jul filing) | | Public First Action spend | Ongoing through Nov 2026 | $20M war chest for midterm candidates; which races, which parties | Through Nov 3, 2026 | | LTBT trustee actions | Irregular | Board appointments, charter amendments, trustee changes | Ongoing — Narasimhan seated Apr 2026 | | S-1 amendments | Irregular | SEC review cycles, public filing, pricing | Q3–Q4 2026 | | Revenue milestones | Irregular | ARR benchmarks (crossed $47B annualized mid-2026) | Ongoing | ## Upcoming dated beats | Date | Event | Status | |------|-------|--------| | Q3 2026 | S-1 expected to become public | Pending — confidential filing Jun 1 | | Oct 2026 (target) | Nasdaq IPO | Pending — depends on market conditions and SEC review | | Nov 3, 2026 | Midterm elections | Public First Action spending window closes | | TBD | D.C. Circuit oral argument on FASCSA | Was scheduled May 19, 2026; check for decision | | TBD | FASCSA designation appeal ruling | Pending — expedited briefing ordered | | TBD | Injunction appeal | Government may appeal Judge Lin's preliminary injunction | ## Predicted beats (undated but expected) - **IPO roadshow** — pre-IPO investor presentations once S-1 goes public; watch for valuation range and governance disclosures - **LTBT majority threshold** — the trust gains power to elect a majority of directors upon certain milestones; timeline unclear from public filings - **Mythos general availability** — currently restricted to approved programs; full rollout would signal government export control resolution - **Defense contract resolution** — either the FASCSA designation is lifted and Anthropic re-enters defense work, or the ban becomes permanent and the market bifurcates between "safety-constrained" and "unrestricted" AI vendors - **New enterprise partnerships** — TCS and DXC deals (announced Jun 2026) signal push into regulated industries (banking, healthcare) - **Life sciences division** — [[John Jumper]] hire implies a dedicated AI-for-science effort; watch for product announcements - **International expansion** — Seoul office opened Jun 2026; London, Tokyo likely next ## See Also - [[Anthropic Dossier]] — the document collection front door - [[Anthropic Watch Log]] — the running OSINT feed - [[OpenAI Calendar]] — the competitor's beats calendar